Trauma has a become a dominant causal explanation in psychological and public health accounts of drug use, with drug consumption typically framed as a coping response or form of self-medication. Drawing on Lauren Berlant's work (2008, 2011), particularly their concepts of genre, crisis ordinariness and lateral agency, we examine the affective and political conventions of trauma as a genre for...
Australia recently down-scheduled and authorised psychedelic-assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness. While service leaders and clinicians are crucial to implementation, little research examines their...
Background Ibogaine is a psychedelic drug used by for-profit clinics and lay-people to treat addiction, despite some reported fatalities and a lack of rigorous clinical research. Little is known about ibogaine therapy from a consumer perspective. Online discussions generate and disseminate information about ibogaine therapy and provide a window into how people understand ibogaine's risks and...